• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织因子通过一条独立于血液凝固的途径促进黑色素瘤转移。

Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation.

作者信息

Bromberg M E, Konigsberg W H, Madison J F, Pawashe A, Garen A

机构信息

Department of Medicine, Yale University School of Medicine, New Haven, CT 06520-8024, USA.

出版信息

Proc Natl Acad Sci U S A. 1995 Aug 29;92(18):8205-9. doi: 10.1073/pnas.92.18.8205.

DOI:10.1073/pnas.92.18.8205
PMID:7667269
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC41125/
Abstract

Several studies have established a link between blood coagulation and cancer, and more specifically between tissue factor (TF), a transmembrane protein involved in initiating blood coagulation, and tumor metastasis. In the study reported here, a murine model of human melanoma metastasis was used for two experiments. (i) The first experiment was designed to test the effect of varying the level of TF expression in human melanoma cells on their metastatic potential. Two matched sets of cloned human melanoma lines, one expressing a high level and the other a low level of the normal human TF molecule, were generated by retroviral-mediated transfections of a nonmetastatic parental line. The metastatic potential of the two sets of transfected lines was compared by injecting the tumor cells into the tail vein of severe combined immunodeficiency (SCID) mice and later examining the lungs and other tissues for tumor development. Metastatic tumors were detected in 86% of the mice injected with the high-TF lines and in 5% of the mice injected with the low-TF lines, indicating that a high TF level promotes metastasis of human melanoma in the SCID mouse model. This TF effect on metastasis occurs with i.v.-injected melanoma cells but does not occur with primary tumors formed from s.c.-injected melanoma cells, suggesting that TF acts at a late stage of metastasis, after tumor cells have escaped from the primary site and entered the blood. (ii) The second experiment was designed to analyze the mechanism by which TF promotes melanoma metastasis. The procedure involved testing the effect on metastasis of mutations in either the extracellular or cytoplasmic domains of the transmembrane TF molecule. The extracellular mutations introduced two amino acid substitutions that inhibited initiation by TF of the blood-coagulation cascade; the cytoplasmic mutation deleted most of the cytoplasmic domain without impairing the coagulation function of TF. Several human melanoma lines expressing high levels of either of the two mutant TF molecules were generated by retroviral-mediated transfection of the corresponding TF cDNA into the nonmetastatic parental melanoma line, and the metastatic potential of each transfected line was tested in the SCID mouse model. Metastases occurred in most mice injected with the melanoma lines expressing the extracellular TF mutant but were not detected in most mice injected with the melanoma lines expressing the cytoplasmic TF mutant. Results with the extracellular TF mutant indicate that the metastatic effect of TF in the SCID mouse model does not involve products of the coagulation cascade. Results with the cytoplasmic TF mutant indicate that the cytoplasmic domain of TF is important for the metastatic effect, suggesting that the TF could transduce a melanoma cell signal that promotes metastasis.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c66/41125/367968a1bf1f/pnas01496-0127-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c66/41125/367968a1bf1f/pnas01496-0127-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c66/41125/367968a1bf1f/pnas01496-0127-a.jpg
摘要

多项研究证实了血液凝固与癌症之间的联系,更具体地说,是参与启动血液凝固的跨膜蛋白组织因子(TF)与肿瘤转移之间的联系。在本文报道的研究中,人类黑色素瘤转移的小鼠模型被用于两项实验。(i)第一个实验旨在测试改变人类黑色素瘤细胞中TF表达水平对其转移潜能的影响。通过逆转录病毒介导的非转移性亲代细胞系转染,产生了两组匹配的克隆人类黑色素瘤细胞系,一组表达高水平的正常人TF分子,另一组表达低水平的正常人TF分子。通过将肿瘤细胞注入严重联合免疫缺陷(SCID)小鼠的尾静脉,然后检查肺部和其他组织中肿瘤的发展情况,比较两组转染细胞系的转移潜能。在注射高TF细胞系的小鼠中,86%检测到转移性肿瘤,而在注射低TF细胞系的小鼠中,这一比例为5%,表明高TF水平促进了人类黑色素瘤在SCID小鼠模型中的转移。TF对转移的这种作用在静脉注射黑色素瘤细胞时出现,但在皮下注射黑色素瘤细胞形成的原发性肿瘤中未出现,这表明TF在肿瘤细胞从原发部位逃逸并进入血液后的转移后期起作用。(ii)第二个实验旨在分析TF促进黑色素瘤转移的机制。该实验过程包括测试跨膜TF分子细胞外或细胞质结构域突变对转移的影响。细胞外突变引入了两个氨基酸替代,抑制了TF启动血液凝固级联反应;细胞质突变删除了大部分细胞质结构域,而不损害TF的凝血功能。通过逆转录病毒介导将相应的TF cDNA转染到非转移性亲代黑色素瘤细胞系中,产生了几种表达两种突变TF分子中任一种的高水平的人类黑色素瘤细胞系,并在SCID小鼠模型中测试了每个转染细胞系的转移潜能。在大多数注射表达细胞外TF突变体的黑色素瘤细胞系的小鼠中发生了转移,但在大多数注射表达细胞质TF突变体的黑色素瘤细胞系的小鼠中未检测到转移。细胞外TF突变体的结果表明,TF在SCID小鼠模型中的转移作用不涉及凝血级联反应的产物。细胞质TF突变体的结果表明,TF的细胞质结构域对转移作用很重要,这表明TF可能转导一种促进转移的黑色素瘤细胞信号。

相似文献

1
Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation.组织因子通过一条独立于血液凝固的途径促进黑色素瘤转移。
Proc Natl Acad Sci U S A. 1995 Aug 29;92(18):8205-9. doi: 10.1073/pnas.92.18.8205.
2
Role of tissue factor in metastasis: functions of the cytoplasmic and extracellular domains of the molecule.组织因子在转移中的作用:该分子胞质域和胞外域的功能
Thromb Haemost. 1999 Jul;82(1):88-92.
3
Role of protease-activated receptor 1 in tumor metastasis promoted by tissue factor.蛋白酶激活受体1在组织因子促进肿瘤转移中的作用
Thromb Haemost. 2001 Nov;86(5):1210-4.
4
Retroviral-mediated transmission of a mouse VL30 RNA to human melanoma cells promotes metastasis in an immunodeficient mouse model.逆转录病毒介导的小鼠VL30 RNA向人黑色素瘤细胞的传递在免疫缺陷小鼠模型中促进转移。
Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6269-73. doi: 10.1073/pnas.092112199. Epub 2002 Apr 16.
5
Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor.组织因子胞质尾对血管内皮生长因子产生及血管生成的调控
Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8663-8. doi: 10.1073/pnas.96.15.8663.
6
Downregulation of tissue factor by RNA interference in human melanoma LOX-L cells reduces pulmonary metastasis in nude mice.通过RNA干扰下调人黑色素瘤LOX-L细胞中的组织因子可减少裸鼠的肺转移。
Int J Cancer. 2004 Dec 20;112(6):994-1002. doi: 10.1002/ijc.20527.
7
Regulation of vascular endothelial growth factor (VEGF) production and angiogenesis by tissue Factor (TF) in SGC-7901 gastric cancer cells.组织因子(TF)对SGC-7901胃癌细胞中血管内皮生长因子(VEGF)产生及血管生成的调控
Cancer Biol Ther. 2005 Jul;4(7):769-72. doi: 10.4161/cbt.4.7.1871. Epub 2005 Jul 28.
8
Targeting tumor vasculature endothelial cells and tumor cells for immunotherapy of human melanoma in a mouse xenograft model.在小鼠异种移植模型中靶向肿瘤血管内皮细胞和肿瘤细胞进行人黑色素瘤的免疫治疗。
Proc Natl Acad Sci U S A. 1999 Jul 6;96(14):8161-6. doi: 10.1073/pnas.96.14.8161.
9
Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis.黑色素瘤细胞表达组织因子可促进有效的血行转移。
Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):11832-6. doi: 10.1073/pnas.89.24.11832.
10
Alternatively spliced human tissue factor promotes tumor growth and angiogenesis in a pancreatic cancer tumor model.可变剪接的人组织因子在胰腺癌肿瘤模型中促进肿瘤生长和血管生成。
Thromb Res. 2007;120 Suppl 2:S13-21. doi: 10.1016/S0049-3848(07)70126-3.

引用本文的文献

1
The Dynamic Landscape of the Coagulome of Metastatic Malignant Melanoma.转移性恶性黑色素瘤凝血组的动态格局
Int J Mol Sci. 2025 Feb 8;26(4):1435. doi: 10.3390/ijms26041435.
2
Conversion of anti-tissue factor antibody sequences to chimeric antigen receptor and bi-specific T-cell engager format.将抗组织因子抗体序列转化为嵌合抗原受体和双特异性 T 细胞衔接器形式。
Cancer Immunol Immunother. 2024 Aug 6;73(10):195. doi: 10.1007/s00262-024-03778-3.
3
Antibody-drug conjugates in cancer therapy: mechanisms and clinical studies.癌症治疗中的抗体药物偶联物:作用机制与临床研究

本文引用的文献

1
The multistep nature of cancer.癌症的多步骤特性。
Trends Genet. 1993 Apr;9(4):138-41. doi: 10.1016/0168-9525(93)90209-z.
2
Blockade of human immunodeficiency virus type 1 production in CD4+ T cells by an intracellular CD4 expressed under control of the viral long terminal repeat.在病毒长末端重复序列控制下表达的细胞内CD4对CD4+ T细胞中1型人类免疫缺陷病毒产生的阻断作用。
Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2695-9. doi: 10.1073/pnas.90.7.2695.
3
Synthesis of tissue factor messenger RNA and procoagulant activity in breast cancer cells in response to serum stimulation.
MedComm (2020). 2024 Jul 28;5(8):e671. doi: 10.1002/mco2.671. eCollection 2024 Aug.
4
Monitoring circulating platelet activity to predict cancer-associated thrombosis.监测循环血小板活性以预测癌症相关血栓形成。
Cell Rep Methods. 2023 Jun 27;3(7):100513. doi: 10.1016/j.crmeth.2023.100513. eCollection 2023 Jul 24.
5
CD142 Identifies Neoplastic Desmoid Tumor Cells, Uncovering Interactions Between Neoplastic and Stromal Cells That Drive Proliferation.CD142 鉴定肿瘤性成纤维细胞源性肿瘤细胞,揭示驱动增殖的肿瘤细胞与基质细胞之间的相互作用。
Cancer Res Commun. 2023 Apr 25;3(4):697-708. doi: 10.1158/2767-9764.CRC-22-0403. eCollection 2023 Apr.
6
Tissue factor (coagulation factor III): a potential double-edge molecule to be targeted and re-targeted toward cancer.组织因子(凝血因子III):一种有望针对癌症进行靶向及重新靶向的潜在双刃剑分子。
Biomark Res. 2023 Jun 6;11(1):60. doi: 10.1186/s40364-023-00504-6.
7
The Tissue Factor Pathway in Cancer: Overview and Role of Heparan Sulfate Proteoglycans.癌症中的组织因子途径:硫酸乙酰肝素蛋白聚糖的概述及作用
Cancers (Basel). 2023 Feb 28;15(5):1524. doi: 10.3390/cancers15051524.
8
Survival outcomes with warfarin compared with direct oral anticoagulants in cancer-associated venous thromboembolism in the United States: A population-based cohort study.在美国,癌症相关静脉血栓栓塞症中,华法林与直接口服抗凝剂相比的生存结局:一项基于人群的队列研究。
PLoS Med. 2022 May 25;19(5):e1004012. doi: 10.1371/journal.pmed.1004012. eCollection 2022 May.
9
Overall survival with warfarin vs. low-molecular-weight heparin in cancer-associated thrombosis.癌症相关性血栓形成中,华法林与低分子肝素的总生存率比较。
J Thromb Haemost. 2021 Nov;19(11):2825-2834. doi: 10.1111/jth.15519. Epub 2021 Sep 21.
10
Targeting Tissue Factor to Tumor Vasculature to Induce Tumor Infarction.将组织因子靶向肿瘤血管以诱导肿瘤梗死。
Cancers (Basel). 2021 Jun 7;13(11):2841. doi: 10.3390/cancers13112841.
乳腺癌细胞中组织因子信使核糖核酸的合成及凝血活性对血清刺激的反应。
Thromb Res. 1993 Oct 15;72(2):155-68. doi: 10.1016/0049-3848(93)90217-c.
4
Binding of human factor VIIa to tissue factor induces cytosolic Ca2+ signals in J82 cells, transfected COS-1 cells, Madin-Darby canine kidney cells and in human endothelial cells induced to synthesize tissue factor.人因子VIIa与组织因子的结合在J82细胞、转染的COS-1细胞、犬肾细胞以及诱导合成组织因子的人内皮细胞中诱导胞质Ca2+信号。
J Biol Chem. 1995 Mar 3;270(9):4650-60. doi: 10.1074/jbc.270.9.4650.
5
Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice.组织因子控制小鼠肿瘤细胞血管生成和抗血管生成特性的平衡。
J Clin Invest. 1994 Sep;94(3):1320-7. doi: 10.1172/JCI117451.
6
Activation of blood coagulation in cancer: Trousseau's syndrome revisited.癌症中血液凝固的激活:重新审视特鲁索综合征。
Blood. 1983 Jul;62(1):14-31.
7
Factor VII binding to tissue factor in reconstituted phospholipid vesicles: induction of cooperativity by phosphatidylserine.重组磷脂囊泡中凝血因子VII与组织因子的结合:磷脂酰丝氨酸诱导协同作用。
Biochemistry. 1986 Jul 15;25(14):4007-20. doi: 10.1021/bi00362a005.
8
Tissue factor and hemostasis.组织因子与止血
Blood. 1988 Jan;71(1):1-8.
9
Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA.编码人组织因子的cDNA克隆的分离:该蛋白质和cDNA的一级结构
Proc Natl Acad Sci U S A. 1987 Aug;84(15):5148-52. doi: 10.1073/pnas.84.15.5148.
10
The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function.严重联合免疫缺陷-人源化小鼠:用于分析人类血液淋巴细胞分化与功能的小鼠模型。
Science. 1988 Sep 23;241(4873):1632-9. doi: 10.1126/science.241.4873.1632.